The Leukemia & Lymphoma Society is currently accepting Letters of Intent for the Specialized Center of Research Program.
A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application. The quality and significance of the Projects and Cores, and the enhanced productivity that is likely to be achieved by linking the investigators, are the primary determinants of funding decisions.
Each SCOR is comprised of a minimum of three scientific Projects and a minimum of two scientific Cores that will cooperate under the leadership of a SCOR Director. There must be objective evidence of interdisciplinary research among the Projects and Cores.
The maximal annual total cost is $1,000,000 for each year of the five year grant. The maximum annual direct cost is $833,333.33 while the maximum annual indirect cost is $166,666.66. The SCOR Director has the authority to budget these funds among the various Projects and Cores.
How to Apply/Deadlines
LLS uses its own Research Portal powered by FLUXX for Letter of Intent (LOI) and full application submission.
|Call for Proposals||August 1, 2019|
|Letter of Intent Deadline||October 1, 2019, 3:00 PM (EDT)|
|Notice of Full Application Invitation||December 2019|
|Full Application Deadline||March 15, 2020, 3:00 PM (EST)|
|Notification of Awards||August 2020|
|Signed Contract, Lay Abstract, and Scientific Abstract due to LLS||September 1, 2020|
|Funding start date||October 1, 2020|
During the review process, in addition to a Priority Score, each application will be assigned a Mission Score, which evaluates the alignment of the proposal with the intention of the award mechanism; it does not evaluate the scientific/clinical quality of the research. Though the Priority Score is the most prominent for funding decisions, the Mission Score may be used to distinguish between two applications with similar Priority Scores. For example, an application with a Mission Score of 1 may be funded over an application with the same/similar Priority Score, but with a Mission Score of 3.
Mission Score of 1: There is a very high degree of integration between basic and translational research with strong potential to lead to a clinical trial during the duration of the award.
Mission Score of 2: There is a very high degree of integration between basic and translational research with a moderate potential to lead to a clinical trial during the duration of the award.
Mission Score of 3: There is a moderate degree of integration between basic and translational research with a limited potential to lead to a clinical trial during the duration of the award.
SCOR Application FAQ